Aziz Kabeer
Insider CIK 1914847 · ANTX Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ANTX AN2 Therapeutics, Inc. | A Award | 2026-10-12 | 2026-10-13 | 2,465 | — | $0 | 61,571 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2026-07-10 | 2026-07-10 | 2,852 | — | $0 | 59,106 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2026-04-10 | 2026-04-10 | 3,775 | — | $0 | 56,254 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-23 | 23,742 | — | $0 | 23,742 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-23 | 23,742 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-23 | 20,724 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-23 | 20,724 | — | $0 | 20,724 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-02-20 | 2026-02-23 | 20,400 | — | $0 | 20,400 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2026-01-12 | 2026-01-14 | 11,560 | — | $0 | 52,479 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2025-10-10 | 2025-10-14 | 10,367 | — | $0 | 40,919 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2025-07-10 | 2025-07-11 | 11,875 | — | $0 | 30,552 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2025-05-22 | 2025-05-23 | 19,111 | — | $0 | 19,111 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2025-04-10 | 2025-04-11 | 9,705 | — | $0 | 18,677 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2024-12-19 | 2024-12-23 | 8,972 | — | $0 | 8,972 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2024-06-19 | 2024-06-21 | 64,503 | — | $0 | 64,503 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2024-01-16 | 2024-01-18 | 15,907 | $19.65 | $312.6K | 377,542 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2024-01-16 | 2024-01-18 | 84,093 | $19.65 | $1.65M | 1,995,958 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2023-11-14 | 2023-11-16 | 1,522 | $16.15 | $24.6K | 2,080,051 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2023-11-14 | 2023-11-16 | 288 | $16.15 | $4.7K | 393,449 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2023-10-02 | 2023-10-03 | 4,770 | $16.07 | $76.7K | 2,081,573 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2023-10-02 | 2023-10-03 | 902 | $16.07 | $14.5K | 393,737 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2023-09-29 | 2023-10-03 | 83,337 | $16.28 | $1.36M | 2,086,343 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2023-09-29 | 2023-10-03 | 15,764 | $16.28 | $256.6K | 394,639 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2023-09-28 | 2023-09-29 | 1,356 | $16.11 | $21.8K | 410,403 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2023-09-28 | 2023-09-29 | 7,160 | $16.11 | $115.3K | 2,169,680 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2023-09-27 | 2023-09-29 | 707 | $16.07 | $11.4K | 2,176,840 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2023-09-27 | 2023-09-29 | 134 | $16.07 | $2.2K | 411,759 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2023-09-13 | 2023-09-15 | 336 | $16.00 | $5.4K | 2,177,547 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2023-09-13 | 2023-09-15 | 64 | $16.00 | $1.0K | 411,893 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2023-09-07 | 2023-09-08 | 2,841 | $16.05 | $45.6K | 2,177,883 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2023-09-07 | 2023-09-08 | 537 | $16.05 | $8.6K | 411,957 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2023-09-06 | 2023-09-08 | 598 | $16.02 | $9.6K | 412,494 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2023-09-06 | 2023-09-08 | 3,164 | $16.02 | $50.7K | 2,180,724 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2023-08-23 | 2023-08-25 | 64 | $16.00 | $1.0K | 413,092 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2023-08-23 | 2023-08-25 | 336 | $16.00 | $5.4K | 2,183,888 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 23,742 | — | $0 | 23,742 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | J Other | 2022-06-06 | 2022-06-24 | 26,511 | $15.00 | $397.7K | 2,184,224 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | J Other | 2022-06-06 | 2022-06-24 | 26,511 | $15.00 | $397.7K | 413,156 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2022-05-12 | 2022-05-16 | 20,724 | — | $0 | 20,724 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | C Conversion deriv | 2022-03-29 | 2022-03-31 | 1,651,636 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | C Conversion deriv | 2022-03-29 | 2022-03-31 | 312,415 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | C Conversion deriv | 2022-03-29 | 2022-03-31 | 392,433 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | C Conversion deriv | 2022-03-29 | 2022-03-31 | 74,230 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | C Conversion | 2022-03-29 | 2022-03-31 | 74,230 | — | $0 | 386,645 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | P Buy | 2022-03-29 | 2022-03-31 | 166,666 | $15.00 | $2.50M | 2,210,735 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | C Conversion | 2022-03-29 | 2022-03-31 | 312,415 | — | $0 | 312,415 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | C Conversion | 2022-03-29 | 2022-03-31 | 1,651,636 | — | $0 | 1,651,636 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | C Conversion | 2022-03-29 | 2022-03-31 | 392,433 | — | $0 | 2,044,069 | SEC↗ |